BIG
GMAB icon

Brooklyn Investment Group’s Genmab GMAB Stock Holding History

Brooklyn Investment Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$961K Buy
35,823
+6,637
+23% +$199K 0.03% 587
2025
Q4 		$949K Buy
+29,186
New +$910K 0.04% 375
2025
Q3 		– Sell
-7,354
Closed -$152K – 1484
2025
Q2 		$152K Buy
7,354
+3,108
+73% +$63.8K 0.02% 735
2025
Q1 		$83.1K Buy
4,246
+3,734
+729% +$78.3K 0.02% 576
2024
Q4 		$10.7K Buy
+512
New +$11.2K ﹤0.01% 953

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Brooklyn Investment Group's GMAB Position: Q1 2026 in Review

Brooklyn Investment Group increased its Genmab (GMAB) stake by 23% in Q1 2026, buying an estimated $199K and bringing the position to 35,823 shares worth $961K. The position accounts for 0.03% of the portfolio, ranked #587.

Brooklyn Investment Group first reported a position in GMAB in Q4 2024 and has held it in 5 quarters since. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Brooklyn Investment Group held 35,823 shares of Genmab worth $961K as of Q1 2026.
  • Brooklyn Investment Group bought 6,637 Genmab shares in Q1 2026, an estimated $199K.
  • Genmab made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #587 holding.
  • Brooklyn Investment Group first reported a position in Genmab in Q4 2024 and has held it in 5 quarters since.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.